Sign in
Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial
Journal article   Open access  Peer reviewed

Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial

Shoaib Ashraf, Sohaib Ashraf, Iqra Farooq, Sidra Ashraf, Moneeb Ashraf, Muhammad Ahmad Imran, Larab Kalsoom, Rutaba Akmal, Muhammad Ghufran, Sundas Rafique, …
Trials, Vol.22(1), pp.591-591
06/09/2021
PMID: 34488858

Abstract

COVID-19 Ivermectin Letter Pakistan protocol Randomised controlled trial Subcutaneous Ivermectin Zinc
url
https://doi.org/10.1186/s13063-021-05487-zView
Published (Version of record) Open

Details